Search
Tolterodine
go.drugbank.com/drugs/DB01036ApprovedInvestigationalTolterodine acts on M2 and M3 subtypes of muscarinic receptors.
Products: TOLTERODIN HEXAL RET 4 MG, Mylan-tolterodine ERXylometazoline
go.drugbank.com/drugs/DB06694ApprovedIn some countries, it is available as combination products with [ipratropium], [domiphen], or [dexpanthenol].
Mixtures: nasic - Nasenspray 10 mg/500 mg, nasic - Nasenspray für Kinder 5 mg/500 mgProducts: XILOMETAZOLINA EG, OTRIVINE MENTOL 1 MG/ML DOZ AYARLI BURUN SPREYI, ÇÖZELTİ, 10 MLLapatinib
go.drugbank.com/drugs/DB01259ApprovedInvestigationalIt was approved by the FDA on March 13, 2007, for use in patients with advanced metastatic breast cancer in conjunction with the chemotherapy drug capecitabine. … It binds to the intracellular phosphorylation domain to prevent receptor autophosphorylation upon ligand binding.
Products: TYKERB 250 MG FILM TABLET, 70 ADET, LAPATINIB EGLurasidone
go.drugbank.com/drugs/DB08815ApprovedInvestigationalIt was approved by the U.S. … Food and Drug Administration (FDA) for treatment of schizophrenia on October 29, 2010 and is currently pending approval for the treatment of bipolar disorder in the United States.
Products: LATUDA® 20 MG TABLETAS RECUBIERTAS, LUİGON 20 MG FİLM KAPLI TABLET, 30 ADETPalonosetron
go.drugbank.com/drugs/DB00377ApprovedInvestigationalAs of 2008, it is the most recent 5-HT3 antagonist to enter clinical use. … It is the most effective of the 5-HT3 antagonists in controlling delayed CINV nausea and vomiting that appear more than 24 hours after the first dose of a course of chemotherapy and is the only drug of
Synonyms: 2-(1-Azabicyclo(2.2.2)oct-3-yl)-2,3,3a,4,5,6-hexahydro-1H-benz(de)isoquinolin-1-one, (3aS)-2-[(3S)-1-azabicyclo[2.2.2]octan-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinolin-1-oneProducts: SOFT CAPSULES 500 mcg, PALSET (Palonosetron Hydrochloride Solution for Injection 0.05 mg/ml, 5 ml vial)Pazopanib
go.drugbank.com/drugs/DB06589ApprovedInvestigationalIt is developed by GlaxoSmithKline and was FDA approved on October 19, 2009.
Products: VOTRIENT® 200 MG, Votrient Tablet 200 mgGonadorelin
go.drugbank.com/drugs/DB00644ApprovedInvestigationalVet approvedIt is a synthetic decapeptide prepared using solid phase peptide synthesis. GnRH is responsible for the release of follicle stimulating hormone and leutinizing hormone from the anterior pituitary.
Mixtures: Relisorm 100 for Inj.-pws Liq-kit Sc IV, Relisorm 500 for Inj.-pws Liq-kit IV ScProducts: LH-RH FERRING 0,1 MG/ML IV ENJEKSIYONLUK COZELTI ICEREN AMPUL, 1 ADET, Kryptocur 0,2 mg/0,1 ml - nasale SprühlösungGefitinib
go.drugbank.com/drugs/DB00317ApprovedInvestigationalIt is marketed by AstraZeneca under the trade name Iressa.
Products: GEFITINIB EG, GEFTRA® 250 MGAlirocumab
go.drugbank.com/drugs/DB09302ApprovedInvestigationalIt is a human monoclonal antibody part of the family of the PCSK9 inhibitors which are a novel class of anticholesterol therapeutics. From this family, it was the first agent to receive FDA approval.
Products: PRALUENT 150 MG/ML (SOLUTION FOR INJECTION IN PRE-FILLED PEN), PRALUENT SOLUTION FOR INJECTION IN A PRE-FILLED PEN 150 MG/MLGriseofulvin
go.drugbank.com/drugs/DB00400ApprovedVet approvedGriseofulvin may be given by mouth in the treatment of tinea infections.
International brands: Grison-250Products: FUNGOVIN 250 MG TABLET, 100 ADET, FUNGOVIN 500 MG TABLET, 100 ADET